Frazier Management’s Cogent Biosciences COGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,774,891
Closed -$15.2M 10
2021
Q4
$15.2M Buy
+1,774,891
New +$15.4M 1.17% 29

Other funds holding COGT

Frazier Management's COGT Position: Q1 2022 in Review

Frazier Management sold out of Cogent Biosciences (COGT) in Q1 2022, closing a stake of 1,774,891 shares — an estimated $15.2M sold.

Frazier Management first reported a position in COGT in Q4 2021 and held it in 1 quarter. The position peaked at $15.2M in Q4 2021. 87 funds tracked by Wall St. Rank hold COGT as of Q1 2022.

  • Frazier Management reported no remaining Cogent Biosciences position as of Q1 2022 after selling out during the quarter.
  • Frazier Management sold 1,774,891 Cogent Biosciences shares in Q1 2022, an estimated $15.2M.
  • Frazier Management first reported a position in Cogent Biosciences in Q4 2021 and held it in 1 quarter.
  • Frazier Management's Cogent Biosciences position peaked at $15.2M in Q4 2021.
  • 87 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2022.

Based on Frazier Management's 13F filing for Q1 2022, filed 13 May 2022.